跳至主要内容
临床试验/NCT01910363
NCT01910363Unknown2 期

Comparison of Clinical Efficacy of Botulinum Neurotoxin Type A1 and A2 for Post-Stroke Lower Limb Spasticity: Phase 2/3

University of Tokushima1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2013年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
30
试验地点
1
主要终点
Change in Modified Ashworth Scale of the ankle joint

研究概览

简要总结

To test the safety and efficacy of a new generation botulinum toxin preparation A2NTX for treating stroke patients with lower limb spasticity.

  • we study the degree of spasticity in the ankle and knee joints, and walking speed in 30 patients with stroke before and after injecting 300 units of BOTOX or A2NTX in a blinded manner as for the patient, the physician, and the examiner.
  • we also assess the safety of A2NTX and compare it to that of BOTOX.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with lower limb spasticity after stroke
  • duration more than 6 months
  • Modified Ashworth Scale of ankle joint more than 2

排除标准

  • patients with previous botulinum toxin injections to lower limbs
  • patients with serious hepatic, renal or cardiac dysfunction
  • patients with respiratory failure
  • patients who cannot understand the instructions

研究组 & 干预措施

A2NTX

Experimental

single intramuscular injection of 300 units of A2NTX, a purified low molecular weight (150 kDalton) botulinum toxin preparation of type A2

干预措施: A2NTX (Drug)

BOTOX

Active Comparator

single intramuscular injection of 300 units of BOTOX®, a commercially available botulinum toxin preparation of type A1

干预措施: BOTOX (Drug)

结局指标

主要结局

Change in Modified Ashworth Scale of the ankle joint

时间窗: 30-60 days after injection

Modified Ashworth Scale is measured at baseline, 30(27-33) days and 60 (56-63) days after injection. Area under curve of Modified Ashworth Scale changes at day 30 and day 60 after injection

次要结局

  • Change in Functional Independence Measure (FIM)(30 days after injection)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ryuji Kaji

Professor and Chairman, Department of Neurology

University of Tokushima

研究点 (1)

Loading locations...

相似试验

Study of a New Generation Botulinum Toxin A2NTX to... | 临床试验